000 01364 a2200421 4500
005 20250514045600.0
264 0 _c20021120
008 200211s 0 0 eng d
022 _a1474-175X
024 7 _a10.1038/nrc906
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDarnell, James E
245 0 0 _aTranscription factors as targets for cancer therapy.
_h[electronic resource]
260 _bNature reviews. Cancer
_cOct 2002
300 _a740-9 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aApoptosis
650 0 4 _aCytoplasm
_xmetabolism
650 0 4 _aCytoskeletal Proteins
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aModels, Biological
650 0 4 _aMutation
650 0 4 _aNF-kappa B
_xmetabolism
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProtein Binding
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aSignal Transduction
650 0 4 _aTrans-Activators
_xmetabolism
650 0 4 _aTranscription Factors
650 0 4 _aTranscription, Genetic
650 0 4 _aWnt Proteins
650 0 4 _aZebrafish Proteins
650 0 4 _abeta Catenin
773 0 _tNature reviews. Cancer
_gvol. 2
_gno. 10
_gp. 740-9
856 4 0 _uhttps://doi.org/10.1038/nrc906
_zAvailable from publisher's website
999 _c12172299
_d12172299